Kyowa Kirin gets approval in Japan for calcimimetics agent Orkedia Tablets 4mg
Pharmaceutical Business Review
AUGUST 31, 2023
Since the launch in May 2018, its low dosage forms, Orkedia Tablets 1mg and Orkedia Tablets 2mg have helped many patients in the country, stated the company. In March 2018, Orkedia was granted approval in Japan to treat secondary hyperparathyroidism in dialysis patients and was later launched in the country in May 2018.
Let's personalize your content